When it comes to direct-to-consumer advertising for clinical trials, is it just about generating referrals for sites? Or is the quality of the referral more important than quantity?
Watch this clip from our first Pharma15 Live! debate between industry experts. Do you agree or disagree? Comment below!
Topics: Pharma15
Just last week, industry experts Matt Kibby, Shwen Gwee, and Dan Sfera squared off on a live 15-minute showdown, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.
Moderated by Kaitlin Kelleher, conference producer at Cambridge Healthtech Institute, our challengers were tasked with debating many of the burning issues surrounding clinical trial advertising in today's shifting patient recruitment landscape.
We're excited to present the full debate for your viewing pleasure. And for those who were unable to catch the event live, we hope you enjoy it!
Topics: clinical trials, advertising, global patient recruitment, Pharma15
When it comes to clinical trial advertising, is “the juice worth the squeeze,” so to speak? To get at the heart of this issue, BBK Worldwide is bringing together industry experts to square off on the live video stream debate “Does Clinical Trial Advertising Deliver?”
Join us on March 28th at 1:00pm EDT for a live 15-minute showdown between experts, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.
With this lineup, you will not want to miss it!
Topics: global patient recruitment, clinical trials, Patient Recruitment, Pharma15
BBK Worldwide is very excited to be participating in the 9th Annual SCOPE Summit for Clinical Ops Executives. Taking place February 12 – 15 in Orlando FL, SCOPE will offer three days of in-depth discussions addressing the operational, technological and data-related aspects of clinical trial planning and management, with 18 different conferences, 3 plenary keynote sessions and interactive breakout discussions.
Topics: Conferences, life sciences, clinical research
For our latest eBook 21st Century Research Champions, we reached out to physicians to gain a deeper understanding about their attitudes and actions with regard to clinical research, and explored tested strategies in building relationships with physicians to enhance patient recuritment. As it turns out, physicians were more than happy to provide their insights into the value of referring physician programs and to elaborate on their willingness to contribute to clinical research. We interviwed Dr. Eliott Rosenstein -- a physician with more than 40 years of experience and Director of the Institute for Rheumatic and Autoimmune diseases -- to get his take on our latest eBook and the importance of referring physicians in clinical trial patient recruitment.
Topics: Physician Referrals, clinical research, clinical trials, Most Viewed
Picture this: a clammy Nicolas Cage sits hunched forward in the driver’s seat of a $5m hypercar, gripping the top of the steering wheel and staring at an undefined point just beyond the camera.
His grip on the wheel tightens and he punches the accelerator.
In a cacophony of protesting rubber and tire smoke, he’s Gone in 60 Seconds.
Sound familiar? I’m making a tenuous but spellbinding opening remark to get our blood flowing about advertising. Not just advertising in general but also, more specifically, patient recruitment advertising.
Topics: clinical research, advertising, Most Viewed
When patients find themselves interacting with information about their health and well-being, it is the responsibility of healthcare professionals to ensure that these interactions are as meaningful and productive as they can be. In this regard, the informed consent process is among the most important facets of clinical research currently undergoing a digital transformation, and pharmaceutical companies must continue to adopt eConsent across the board.
Topics: clinical trials, clinical research, digital health, Digital Platforms, informed consent
In an age where patients have more choice about treatment options (just think about how the treatment guidelines have evolved for multiple sclerosis or rheumatoid arthritis in the last 10 years for example,) and more clinical trials are being conducted by fewer investigators, there has been a constant upward pressure on competition for clinical trial patients, even as sponsors and third party recruitment companies becomes more innovative and proactive in their approaches to marketing their trials.
Topics: clinical trials, clinical research, Site Engagement, Patient Engagement
It’s clear that the clinical team for each study is tasked with creating and managing an individual study budget. The problem is one-off study purchases do not accrue the benefits of volume discounting. Of course, there are numerous and complicated financial arrangements sponsors make with service providers to create optimal rates for clinical trial support – but what about the simple construct of, “buy one shirt, get another for free?”
Topics: clinical research, clinical trials, Patient Engagement, Patient Recruitment
Facebook recently held a special, invite-only breakfast for drug marketers about recruitment for clinical trials, educating them on targeting consumers and announcing their latest initiative, “clinical trial strategy”.
Topics: Social Media, clinical trials